Creative Medical Technology Holdings, Inc. - Common Stock (CELZ)

The US market session of Friday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

U.S. stock futures declined on Thursday after ending higher on Wednesday. Futures of major benchmark indices were trading lower.

As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

It seems time for the Securities and Exchange Commission to oversee stock advertising and consider a ban, or at least a danger warning label.

CELZ stock results show that Creative Medical Tech missed analyst estimates for earnings per share the second quarter of 2024.

CELZ stock results show that Creative Medical Tech beat analyst estimates for earnings per share the first quarter of 2024.

FDA approval under expanded access for Creative Medical. CELZ-201, a pioneering cell-based program, targets abnormal glucose tolerance to prevent Type 1 diabetes.

Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology company has received clearance from the FDA to conduct a phase 1/2 clinical trial using their innovative StemSpine® treatment known as AlloStem™.

It's time for another busy day of trading as we go over the biggest pre-market stock movers worth watching on Tuesday morning!

It's time to start off the week with a breakdown of the biggest pre-market stock movers that investors need to know about for Monday!